In Brief This Week: Agilent; Genomic Health; Vermillion; Strategic Diagnostics; Focus Ahead Consulting, Integrated Genomics; IDBS | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies this week signed a definitive agreement to sell its network solutions business to JDS Uniphase for $165 million in cash. Agilent said that it believes the business, which brought in annual revenues of $162 million for the fiscal year ended Oct. 31, "will be better served by a company that is focused exclusively on communications network testing."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.